Secteur Damora Therapeutics, Inc.

Actions

DMRA

KYG2646Y1044

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 29/07/2026 Varia. 5j. Varia. 1 janv.
28,33 USD -3,70% Graphique intraday de Damora Therapeutics, Inc. -5,54% +23,12%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
-3,70%-5,54%+17,02%+18,39%+23,12%+689,14%-62,48%-74,01% - 1,81 Md
+0,47%+2,27%-1,25%+18,23%+8,20%+50,78%+70,84%+205,72%+5 983,14% 55,01 Md
+2,83%+0,48%+0,26%+13,78%+39,56%+28,18%+82,59%-18,90% - 54,24 Md
+0,54%+1,22%-1,39%-8,49%-2,36%-16,62%-13,47%-70,26% - 23,38 Md
-0,97%-3,30%-1,55%-23,63%-40,75%-1,79%+383,00%+320,21%+800,61% 22,57 Md
-3,71%-2,45%+10,64%+15,86%+21,76%+14,61%-13,20%-67,70% - 20,19 Md
-2,15%-2,30%+8,64%+12,81%-7,89%+27,27%-31,03%-33,39%+54,81% 17,86 Md
-3,01%-6,65%+11,60%+3,71%+24,12%+25,27%+544,34% - - 15,5 Md
-2,09%+0,64%+1,93%+23,81%+26,24%+49,78%+178,74%+228,17%+502,72% 14,2 Md
-3,14%-8,47%-5,67%+85,17%+154,90%+165,37%+292,18%+1 398,85%+622,54% 14,2 Md
+1,50%+1,72%+3,72%+5,46%-6,09%+85,76%+166,11%+532,60%+7 191,73% 12,42 Md
+0,51%-2,80%+7,11%+22,25%+29,87%+441,58%+145,43%+26,20%+1 346,64% 12,08 Md
-1,52%-8,03%+7,38%-30,38%-16,33%-38,12%+130,33%+83,41% - 11,28 Md
-1,34%-4,63%-10,17%+31,56%+23,36%+118,34%+135,74%+166,98%+604,90% 10,79 Md
+1,99%-13,16%-10,61%-38,55%-26,82%-52,13%+503,77%+66,45%+82,86% 10,01 Md
+0,02%0,00%+0,36%+25,09%+23,23%+56,50%+155,59%+561,12% - 9,83 Md
+0,02%+0,19%+127,07%+118,21%+80,19%+186,57%+346,41%+376,59% - 8,84 Md
-2,09%-1,31%+8,55%+36,14%+198,75%+483,60%+579,65%-37,66%-18,44% 8,79 Md
-3,50%-7,56%+8,61%-19,78%+12,08%+24,73%+82,79%-18,69% - 8,49 Md
+0,74%-.--%-.--%-.--%-.--%-.--%+47,55%+79,55% - 8,19 Md
Moyenne -0,77%-1,77%+9,11%+15,48%+28,26%+116,94%+186,24%+196,07%+1 717,15% 16,98 Md
Moyenne pondérée par Capi. -0,16%-0,73%+4,94%+13,53%+22,90%+67,00%+157,42%+173,45%+2 680,63%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action DMRA
  4. Secteur Damora Therapeutics, Inc.